AxoGen (NASDAQ:AXGN) Rating Increased to Buy at StockNews.com

AxoGen (NASDAQ:AXGN – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Friday. AXGN has been the topic of a number of other research reports. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $12.00 price objective on shares of AxoGen […]

Related Keywords

Peterj Mariani , ,Almanack Investment Partners ,Lazard Asset Management ,Nisa Investment Advisors ,Sg Americas Securities ,Canaccord Genuity Group ,Cantor Fitzgerald ,Tower Research Capital ,Axogen Inc ,Get Free Report ,Investment Partners ,Asset Management ,Investment Advisors ,Research Capital ,Avance Nerve Graft ,Axoguard Nerve Connector ,Axoguard Nerve Protector ,Axogen Daily ,Axogen ,Nasdaq Axgn ,Axgn ,Medical ,Upgrade ,Stocknews Com ,